We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+33.7%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$185M
AUM Growth
+$28.5M
Cap. Flow
-$9.89M
Cap. Flow %
-5.33%
Top 10 Hldgs %
96.03%
Holding
21
New
1
Increased
1
Reduced
–
Closed
4

Top Buys

Rank Stock Value
1
ESTA icon
Establishment Labs
ESTA
+$4.11M
2
ATRS
Antares Pharma, Inc.
ATRS
+$309K

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$5.14M
2
JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
+$3.71M
3
BABA icon
Alibaba
BABA
+$3.29M
4
MU icon
Micron Technology
MU
+$2.15M

Sector Composition

Rank Sector Weight
1 Healthcare 76.08%
2 Consumer Discretionary 21.36%
3 Technology 2.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGC
1
Canopy Growth
CGC
$370M
$62.8M 33.89%
129,120
– –
AMZN icon
2
Amazon
AMZN
$2.49T
$39.3M 21.21%
392,540
– –
EGRX
3
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$33M 17.8%
475,755
– –
CRON
4
Cronos Group
CRON
$1.07B
$12.4M 6.66%
1,111,444
– –
ATRS
5
DELISTED
Antares Pharma, Inc.
ATRS
$6.45M 3.48%
1,920,524
+100,000
+5% +$309K
PETQ
6
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$5.85M 3.16%
148,855
– –
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.3M 2.86%
270,775
– –
MSFT icon
8
Microsoft
MSFT
$2.95T
$4.75M 2.56%
41,500
– –
BSTC
9
DELISTED
BioSpecifics Technologies Corp.
BSTC
$4.31M 2.32%
73,649
– –
ESTA icon
10
Establishment Labs
ESTA
$2.76B
$3.86M 2.08%
+160,000
New +$4.11M
LGND icon
11
Ligand Pharmaceuticals
LGND
$5.87B
$3.68M 1.98%
21,482
– –
AVDL
12
DELISTED
Avadel Pharmaceuticals
AVDL
$1.95M 1.05%
444,439
– –
NVLN
13
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$935K 0.5%
315,979
– –
ALIM
14
DELISTED
Alimera Sciences
ALIM
$405K 0.22%
27,553
– –
BBBY
15
Bed Bath & Beyond
BBBY
$480M
$277K 0.15%
13,310
– –
SNOA icon
16
Sonoma Pharmaceuticals
SNOA
$5.31M
$60K 0.03%
228
– –
TLGT
17
DELISTED
Teligent, Inc
TLGT
$55K 0.03%
1,382
– –
BABA icon
18
Alibaba
BABA
$279B
– –
-17,750
Closed -$3.29M
MU icon
19
Micron Technology
MU
$868B
– –
-41,000
Closed -$2.15M
TSLA icon
20
Tesla
TSLA
$1.2T
– –
-225,000
Closed -$5.14M
JNP
21
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
– –
-426,903
Closed -$3.71M

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, JW Asset Management held 21 positions worth $185M, up 18% from $157M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

JW Asset Management withdrew a net $9.89M in Q3 2018, closing 4 positions. Its most notable exit was Tesla, an estimated $5.14M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 69% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, JW Asset Management opened a new position in Establishment Labs worth $3.86M.

  • JW Asset Management's largest Q3 2018 buy was Establishment Labs: 160,000 shares worth $3.86M.
  • JW Asset Management added most to Antares Pharma, Inc. in Q3 2018, an estimated $309K increase.
  • JW Asset Management fully exited Tesla in Q3 2018, selling an estimated $5.14M.
  • JW Asset Management's ten largest holdings make up 96% of its $185M portfolio in Q3 2018.
  • JW Asset Management opened 1 new position and closed 4 in Q3 2018.
  • JW Asset Management's portfolio value rose 18% quarter-over-quarter to $185M.

Based on JW Asset Management's 13F filing for Q3 2018, filed 9 Nov 2018.